| Company/Division name | Nephron Pharmaceuticals |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Total number of jobs (added or to be added): | 380 |
| Year reshoring announced: | 2020 |
| Year reshoring implemented or to be implemented: | 2021 |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 215.8 |
| City reshored to: | West Columbia |
| State(s) reshored to: | SC |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | generic respiratory medicine |
| What domestic positive factors made reshoring more attractive? | Government Incentives, Impact on domestic economy, covid-19 |
